{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,21]],"date-time":"2026-11-21T04:17:01Z","timestamp":1795234621023,"version":"4.10.3"},"reference-count":120,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T00:00:00Z","timestamp":1740009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T00:00:00Z","timestamp":1740009600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-57124-x","type":"journal-article","created":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T16:35:58Z","timestamp":1740069358000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["S1PR1-biased activation drives the resolution of endothelial dysfunction-associated inflammatory diseases by maintaining endothelial integrity"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0716-8987","authenticated-orcid":false,"given":"Huaping","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luhua","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-4417-7731","authenticated-orcid":false,"given":"Kexin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5374-4121","authenticated-orcid":false,"given":"Zheng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoju","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowen","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6370-9549","authenticated-orcid":false,"given":"Jie","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huajing","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8778-4327","authenticated-orcid":false,"given":"Zhongwei","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4549-1697","authenticated-orcid":false,"given":"Kang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingqiu","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1650-2059","authenticated-orcid":false,"given":"J\u00fcrgen","family":"Brosius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3281-4661","authenticated-orcid":false,"given":"Hu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9825-0689","authenticated-orcid":false,"given":"Wei","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7204-801X","authenticated-orcid":false,"given":"Zhenhua","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengming","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5296-8879","authenticated-orcid":false,"given":"Cheng","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,20]]},"reference":[{"key":"57124_CR1","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/S1474-4422(19)30079-1","volume":"18","author":"JM Wardlaw","year":"2019","unstructured":"Wardlaw, J. M., Smith, C. & Dichgans, M. Small vessel disease: mechanisms and clinical implications. Lancet Neurol. 18, 684\u2013696 (2019).","journal-title":"Lancet Neurol."},{"key":"57124_CR2","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1152\/physrev.00035.2003","volume":"84","author":"G Bazzoni","year":"2004","unstructured":"Bazzoni, G. & Dejana, E. Endothelial cell-to-cell junctions: molecular organization and role in vascular homeostasis. Physiol. Rev. 84, 869\u2013901 (2004).","journal-title":"Physiol. Rev."},{"key":"57124_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2019.109485","volume":"66","author":"X Cong","year":"2020","unstructured":"Cong, X. & Kong, W. Endothelial tight junctions and their regulatory signaling pathways in vascular homeostasis and disease. Cell Signal 66, 109485 (2020).","journal-title":"Cell Signal"},{"key":"57124_CR4","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1152\/physrev.00037.2018","volume":"99","author":"N Wettschureck","year":"2019","unstructured":"Wettschureck, N., Strilic, B. & Offermanns, S. Passing the Vascular Barrier: Endothelial Signaling Processes Controlling Extravasation. Physiol. Rev. 99, 1467\u20131525 (2019).","journal-title":"Physiol. Rev."},{"key":"57124_CR5","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/nature17040","volume":"529","author":"S Rafii","year":"2016","unstructured":"Rafii, S., Butler, J. M. & Ding, B. S. Angiocrine functions of organ-specific endothelial cells. Nature 529, 316\u2013325 (2016).","journal-title":"Nature"},{"key":"57124_CR6","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/s41581-018-0098-z","volume":"15","author":"N Jourde-Chiche","year":"2019","unstructured":"Jourde-Chiche, N. et al. Endothelium structure and function in kidney health and disease. Nat. Rev. Nephrol. 15, 87\u2013108 (2019).","journal-title":"Nat. Rev. Nephrol."},{"key":"57124_CR7","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1136\/gut.2010.207480","volume":"60","author":"S Danese","year":"2011","unstructured":"Danese, S. Role of the vascular and lymphatic endothelium in the pathogenesis of inflammatory bowel disease: \u2018brothers in arms. Gut 60, 998\u20131008 (2011).","journal-title":"Gut"},{"key":"57124_CR8","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1146\/annurev-pathol-042320-030240","volume":"17","author":"BJ Moss","year":"2022","unstructured":"Moss, B. J., Ryter, S. W. & Rosas, I. O. Pathogenic Mechanisms Underlying Idiopathic Pulmonary Fibrosis. Annu. Rev. Pathol. 17, 515\u2013546 (2022).","journal-title":"Annu. Rev. Pathol."},{"key":"57124_CR9","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1148\/radiology.217.3.r00dc19787","volume":"217","author":"J Spalinger","year":"2000","unstructured":"Spalinger, J. et al. Doppler US in patients with crohn disease: vessel density in the diseased bowel reflects disease activity. Radiology 217, 787\u2013791 (2000).","journal-title":"Radiology"},{"key":"57124_CR10","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1002\/eji.200838316","volume":"39","author":"F Scaldaferri","year":"2009","unstructured":"Scaldaferri, F. et al. The role of MAPK in governing lymphocyte adhesion to and migration across the microvasculature in inflammatory bowel disease. Eur. J. Immunol. 39, 290\u2013300 (2009).","journal-title":"Eur. J. Immunol."},{"key":"57124_CR11","doi-asserted-by":"publisher","first-page":"2617","DOI":"10.4049\/jimmunol.176.4.2617","volume":"176","author":"S Danese","year":"2006","unstructured":"Danese, S. et al. TNF-alpha blockade down-regulates the CD40\/CD40L pathway in the mucosal microcirculation: a novel anti-inflammatory mechanism of infliximab in Crohn\u2019s disease. J. Immunol. 176, 2617\u20132624 (2006).","journal-title":"J. Immunol."},{"key":"57124_CR12","doi-asserted-by":"publisher","first-page":"S279","DOI":"10.1097\/00054725-200810001-00131","volume":"14","author":"BR Yacyshyn","year":"2008","unstructured":"Yacyshyn, B. R. Adhesion molecule therapeutics in IBD. Inflamm. Bowel Dis. 14, S279\u2013S280 (2008).","journal-title":"Inflamm. Bowel Dis."},{"key":"57124_CR13","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/nri1132","volume":"3","author":"G Bouma","year":"2003","unstructured":"Bouma, G. & Strober, W. The immunological and genetic basis of inflammatory bowel disease. Nat. Rev. Immunol. 3, 521\u2013533 (2003).","journal-title":"Nat. Rev. Immunol."},{"key":"57124_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2017.74","volume":"3","author":"FJ Martinez","year":"2017","unstructured":"Martinez, F. J. et al. Idiopathic pulmonary fibrosis. Nat. Rev. Dis. Prim. 3, 17074 (2017).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"57124_CR15","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/j.cell.2015.02.010","volume":"160","author":"ME Kotas","year":"2015","unstructured":"Kotas, M. E. & Medzhitov, R. Homeostasis, inflammation, and disease susceptibility. Cell 160, 816\u2013827 (2015).","journal-title":"Cell"},{"key":"57124_CR16","doi-asserted-by":"publisher","first-page":"S97","DOI":"10.1038\/540S97a","volume":"540","author":"R Hodson","year":"2016","unstructured":"Hodson, R. Inflammatory bowel disease. Nature 540, S97 (2016).","journal-title":"Nature"},{"key":"57124_CR17","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1016\/S0140-6736(17)30866-8","volume":"389","author":"L Richeldi","year":"2017","unstructured":"Richeldi, L., Collard, H. R. & Jones, M. G. Idiopathic pulmonary fibrosis. Lancet 389, 1941\u20131952 (2017).","journal-title":"Lancet"},{"key":"57124_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.651415","volume":"12","author":"B Al-Bawardy","year":"2021","unstructured":"Al-Bawardy, B., Shivashankar, R. & Proctor, D. D. Novel and emerging therapies for inflammatory bowel disease. Front. Pharm. 12, 651415 (2021).","journal-title":"Front. Pharm."},{"key":"57124_CR19","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1159\/000442925","volume":"34","author":"S Danese","year":"2016","unstructured":"Danese, S. & Fiocchi, C. Endothelial cell-immune cell interaction in IBD. Dig. Dis. 34, 43\u201350 (2016).","journal-title":"Dig. Dis."},{"key":"57124_CR20","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1097\/00054725-199805000-00026","volume":"4","author":"M Salmi","year":"1998","unstructured":"Salmi, M. & Jalkanen, S. Endothelial ligands and homing of mucosal leukocytes in extraintestinal manifestations of IBD. Inflamm. Bowel Dis. 4, 149\u2013156 (1998).","journal-title":"Inflamm. Bowel Dis."},{"key":"57124_CR21","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1016\/j.cell.2019.10.027","volume":"179","author":"B Huang","year":"2019","unstructured":"Huang, B. et al. Mucosal profiling of pediatric-onset colitis and IBD reveals common pathogenics and therapeutic pathways. Cell 179, 1160\u20131176 (2019).","journal-title":"Cell"},{"key":"57124_CR22","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1038\/nri1650","volume":"5","author":"H Rosen","year":"2005","unstructured":"Rosen, H. & Goetzl, E. J. Sphingosine 1-phosphate and its receptors: an autocrine and paracrine network. Nat. Rev. Immunol. 5, 560\u2013570 (2005).","journal-title":"Nat. Rev. Immunol."},{"key":"57124_CR23","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1038\/nri2400","volume":"8","author":"J Rivera","year":"2008","unstructured":"Rivera, J., Proia, R. L. & Olivera, A. The alliance of sphingosine-1-phosphate and its receptors in immunity. Nat. Rev. Immunol. 8, 753\u2013763 (2008).","journal-title":"Nat. Rev. Immunol."},{"key":"57124_CR24","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1146\/annurev.biochem.78.072407.103733","volume":"78","author":"H Rosen","year":"2009","unstructured":"Rosen, H., Gonzalez-Cabrera, P. J., Sanna, M. G. & Brown, S. Sphingosine 1-phosphate receptor signaling. Annu. Rev. Biochem. 78, 743\u2013768 (2009).","journal-title":"Annu. Rev. Biochem."},{"key":"57124_CR25","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/nrd2356","volume":"8","author":"D Marsolais","year":"2009","unstructured":"Marsolais, D. & Rosen, H. Chemical modulators of sphingosine-1-phosphate receptors as barrier-oriented therapeutic molecules. Nat. Rev. Drug Discov. 8, 297\u2013307 (2009).","journal-title":"Nat. Rev. Drug Discov."},{"key":"57124_CR26","doi-asserted-by":"publisher","first-page":"2740","DOI":"10.1111\/jcmm.16333","volume":"25","author":"X Wang","year":"2021","unstructured":"Wang, X., Chen, S., Xiang, H., Liang, Z. & Lu, H. Role of sphingosine-1-phosphate receptors in vascular injury of inflammatory bowel disease. J. Cell Mol. Med. 25, 2740\u20132749 (2021).","journal-title":"J. Cell Mol. Med."},{"key":"57124_CR27","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1111\/apt.16741","volume":"55","author":"J Wang","year":"2022","unstructured":"Wang, J. et al. Review article: the sphingosine 1 phosphate\/sphingosine 1 phosphate receptor axis - a unique therapeutic target in inflammatory bowel disease. Aliment Pharm. Ther. 55, 277\u2013291 (2022).","journal-title":"Aliment Pharm. Ther."},{"key":"57124_CR28","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/nature04606","volume":"440","author":"LR Shiow","year":"2006","unstructured":"Shiow, L. R. et al. CD69 acts downstream of interferon-alpha\/beta to inhibit S1P1 and lymphocyte egress from lymphoid organs. Nature 440, 540\u2013544 (2006).","journal-title":"Nature"},{"key":"57124_CR29","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1038\/ni1545","volume":"8","author":"SR Schwab","year":"2007","unstructured":"Schwab, S. R. & Cyster, J. G. Finding a way out: lymphocyte egress from lymphoid organs. Nat. Immunol. 8, 1295\u20131301 (2007).","journal-title":"Nat. Immunol."},{"key":"57124_CR30","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.ccr.2006.02.023","volume":"9","author":"B Visentin","year":"2006","unstructured":"Visentin, B. et al. Validation of an anti-sphingosine-1-phosphate antibody as a potential therapeutic in reducing growth, invasion, and angiogenesis in multiple tumor lineages. Cancer Cell 9, 225\u2013238 (2006).","journal-title":"Cancer Cell"},{"key":"57124_CR31","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1158\/0008-5472.CAN-17-1423","volume":"78","author":"M Nagahashi","year":"2018","unstructured":"Nagahashi, M. et al. Targeting the SphK1\/S1P\/S1PR1 axis that links obesity, chronic inflammation, and breast cancer metastasis. Cancer Res. 78, 1713\u20131725 (2018).","journal-title":"Cancer Res."},{"key":"57124_CR32","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1056\/NEJMoa2033617","volume":"385","author":"WJ Sandborn","year":"2021","unstructured":"Sandborn, W. J. et al. Ozanimod as induction and maintenance therapy for Ulcerative Colitis. N. Engl. J. Med. 385, 1280\u20131291 (2021).","journal-title":"N. Engl. J. Med."},{"key":"57124_CR33","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1056\/NEJMoa1513248","volume":"374","author":"WJ Sandborn","year":"2016","unstructured":"Sandborn, W. J. et al. Ozanimod induction and maintenance treatment for Ulcerative Colitis. N. Engl. J. Med. 374, 1754\u20131762 (2016).","journal-title":"N. Engl. J. Med."},{"key":"57124_CR34","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1002\/ana.22426","volume":"69","author":"JA Cohen","year":"2011","unstructured":"Cohen, J. A. & Chun, J. Mechanisms of fingolimod\u2019s efficacy and adverse effects in multiple sclerosis. Ann. Neurol. 69, 759\u2013777 (2011).","journal-title":"Ann. Neurol."},{"key":"57124_CR35","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1007\/s40265-022-01762-8","volume":"82","author":"J Paik","year":"2022","unstructured":"Paik, J. Ozanimod: A review in Ulcerative Colitis. Drugs 82, 1303\u20131313 (2022).","journal-title":"Drugs"},{"key":"57124_CR36","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.devcel.2012.08.005","volume":"23","author":"K Gaengel","year":"2012","unstructured":"Gaengel, K. et al. The sphingosine-1-phosphate receptor S1PR1 restricts sprouting angiogenesis by regulating the interplay between VE-cadherin and VEGFR2. Dev. Cell 23, 587\u2013599 (2012).","journal-title":"Dev. Cell"},{"key":"57124_CR37","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1161\/CIRCRESAHA.120.316711","volume":"128","author":"A Nitzsche","year":"2021","unstructured":"Nitzsche, A. et al. Endothelial S1P(1) signaling counteracts infarct expansion in ischemic stroke. Circ. Res. 128, 363\u2013382 (2021).","journal-title":"Circ. Res."},{"key":"57124_CR38","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1016\/j.apsb.2022.10.006","volume":"13","author":"M Hao","year":"2023","unstructured":"Hao, M. et al. S1PR1 serves as a viable drug target against pulmonary fibrosis by increasing the integrity of the endothelial barrier of the lung. Acta Pharm. Sin. B 13, 1110\u20131127 (2023).","journal-title":"Acta Pharm. Sin. B"},{"key":"57124_CR39","doi-asserted-by":"publisher","unstructured":"Poirier, B. et al. A G protein-biased S1P(1) agonist, SAR247799, protects endothelial cells without affecting lymphocyte numbers. Sci. Signal 13, https:\/\/doi.org\/10.1126\/scisignal.aax8050 (2020).","DOI":"10.1126\/scisignal.aax8050"},{"key":"57124_CR40","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1111\/bcp.14422","volume":"87","author":"L Bergougnan","year":"2021","unstructured":"Bergougnan, L. et al. First-in-human study of the safety, tolerability, pharmacokinetics and pharmacodynamics of single and multiple oral doses of SAR247799, a selective G-protein-biased sphingosine-1 phosphate receptor-1 agonist for endothelial protection. Br. J. Clin. Pharm. 87, 598\u2013611 (2021).","journal-title":"Br. J. Clin. Pharm."},{"key":"57124_CR41","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1038\/nprot.2017.044","volume":"12","author":"S Wirtz","year":"2017","unstructured":"Wirtz, S. et al. Chemically induced mouse models of acute and chronic intestinal inflammation. Nat. Protoc. 12, 1295\u20131309 (2017).","journal-title":"Nat. Protoc."},{"key":"57124_CR42","doi-asserted-by":"publisher","unstructured":"Cartier, A. & Hla, T. Sphingosine 1-phosphate: Lipid signaling in pathology and therapy. Science 366, https:\/\/doi.org\/10.1126\/science.aar5551 (2019).","DOI":"10.1126\/science.aar5551"},{"key":"57124_CR43","doi-asserted-by":"publisher","unstructured":"Zhou, Q. et al. Common activation mechanism of class A GPCRs. Elife 8, https:\/\/doi.org\/10.7554\/eLife.50279 (2019).","DOI":"10.7554\/eLife.50279"},{"key":"57124_CR44","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1126\/science.1215904","volume":"335","author":"MA Hanson","year":"2012","unstructured":"Hanson, M. A. et al. Crystal structure of a lipid G protein-coupled receptor. Science 335, 851\u2013855 (2012).","journal-title":"Science"},{"key":"57124_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-33121-2","volume":"13","author":"H Akasaka","year":"2022","unstructured":"Akasaka, H. et al. Structure of the active G(i)-coupled human lysophosphatidic acid receptor 1 complexed with a potent agonist. Nat. Commun. 13, 5417 (2022).","journal-title":"Nat. Commun."},{"key":"57124_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28417-2","volume":"13","author":"S Liu","year":"2022","unstructured":"Liu, S. et al. Differential activation mechanisms of lipid GPCRs by lysophosphatidic acid and sphingosine 1-phosphate. Nat. Commun. 13, 731 (2022).","journal-title":"Nat. Commun."},{"key":"57124_CR47","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2117716119","volume":"119","author":"L Yu","year":"2022","unstructured":"Yu, L. et al. Structural insights into sphingosine-1-phosphate receptor activation. Proc. Natl. Acad. Sci. USA 119, e2117716119 (2022).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"57124_CR48","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/s41589-021-00930-3","volume":"18","author":"Z Xu","year":"2022","unstructured":"Xu, Z. et al. Structural basis of sphingosine-1-phosphate receptor 1 activation and biased agonism. Nat. Chem. Biol. 18, 281\u2013288 (2022).","journal-title":"Nat. Chem. Biol."},{"key":"57124_CR49","doi-asserted-by":"publisher","DOI":"10.1126\/science.adh1859","volume":"382","author":"FM Heydenreich","year":"2023","unstructured":"Heydenreich, F. M. et al. Molecular determinants of ligand efficacy and potency in GPCR signaling. Science 382, eadh1859 (2023).","journal-title":"Science"},{"key":"57124_CR50","doi-asserted-by":"publisher","unstructured":"May, J., Mitchell, J. A. & Jenkins, R. G. Beyond epithelial damage: vascular and endothelial contributions to idiopathic pulmonary fibrosis. J. Clin. Invest. 133, https:\/\/doi.org\/10.1172\/JCI172058 (2023).","DOI":"10.1172\/JCI172058"},{"key":"57124_CR51","first-page":"L908","volume":"274","author":"VI Peinado","year":"1998","unstructured":"Peinado, V. I. et al. Endothelial dysfunction in pulmonary arteries of patients with mild COPD. Am. J. Physiol. 274, L908\u2013L913 (1998).","journal-title":"Am. J. Physiol."},{"key":"57124_CR52","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1038\/s41591-018-0087-6","volume":"24","author":"S Rangarajan","year":"2018","unstructured":"Rangarajan, S. et al. Metformin reverses established lung fibrosis in a bleomycin model. Nat. Med. 24, 1121\u20131127 (2018).","journal-title":"Nat. Med."},{"key":"57124_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2020.114147","volume":"180","author":"S Bindu","year":"2020","unstructured":"Bindu, S., Mazumder, S. & Bandyopadhyay, U. Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: A current perspective. Biochem. Pharm. 180, 114147 (2020).","journal-title":"Biochem. Pharm."},{"key":"57124_CR54","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1007\/s11481-011-9312-5","volume":"7","author":"C Cunningham","year":"2012","unstructured":"Cunningham, C. & Skelly, D. T. Non-steroidal anti-inflammatory drugs and cognitive function: are prostaglandins at the heart of cognitive impairment in dementia and delirium? J. Neuroimmune Pharm. 7, 60\u201373 (2012).","journal-title":"J. Neuroimmune Pharm."},{"key":"57124_CR55","doi-asserted-by":"publisher","unstructured":"Fenis, A., Demaria, O., Gauthier, L., Vivier, E. & Narni-Mancinelli, E. New immune cell engagers for cancer immunotherapy. Nat. Rev. Immunol. https:\/\/doi.org\/10.1038\/s41577-023-00982-7 (2024).","DOI":"10.1038\/s41577-023-00982-7"},{"key":"57124_CR56","doi-asserted-by":"publisher","first-page":"S61","DOI":"10.1038\/d41586-017-08699-z","volume":"552","author":"E Bender","year":"2017","unstructured":"Bender, E. Cancer immunotherapy. Nature 552, S61 (2017).","journal-title":"Nature"},{"key":"57124_CR57","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1038\/s41577-022-00680-w","volume":"22","author":"R Hernandez","year":"2022","unstructured":"Hernandez, R., Poder, J., LaPorte, K. M. & Malek, T. R. Engineering IL-2 for immunotherapy of autoimmunity and cancer. Nat. Rev. Immunol. 22, 614\u2013628 (2022).","journal-title":"Nat. Rev. Immunol."},{"key":"57124_CR58","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.it.2019.04.002","volume":"40","author":"KE Pauken","year":"2019","unstructured":"Pauken, K. E., Dougan, M., Rose, N. R., Lichtman, A. H. & Sharpe, A. H. Adverse events following cancer immunotherapy: Obstacles and opportunities. Trends Immunol. 40, 511\u2013523 (2019).","journal-title":"Trends Immunol."},{"key":"57124_CR59","doi-asserted-by":"publisher","first-page":"86","DOI":"10.3322\/caac.21596","volume":"70","author":"LB Kennedy","year":"2020","unstructured":"Kennedy, L. B. & Salama, A. K. S. A review of cancer immunotherapy toxicity. CA Cancer J. Clin. 70, 86\u2013104 (2020).","journal-title":"CA Cancer J. Clin."},{"key":"57124_CR60","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s13181-021-00833-8","volume":"17","author":"N Chhabra","year":"2021","unstructured":"Chhabra, N. & Kennedy, J. A review of cancer immunotherapy toxicity: Immune checkpoint inhibitors. J. Med. Toxicol. 17, 411\u2013424 (2021).","journal-title":"J. Med. Toxicol."},{"key":"57124_CR61","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S0162-3109(97)00041-6","volume":"37","author":"R Baluna","year":"1997","unstructured":"Baluna, R. & Vitetta, E. S. Vascular leak syndrome: a side effect of immunotherapy. Immunopharmacology 37, 117\u2013132 (1997).","journal-title":"Immunopharmacology"},{"key":"57124_CR62","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2023.1213383","volume":"11","author":"E Naschberger","year":"2023","unstructured":"Naschberger, E. et al. Analysis of the interferon-gamma-induced secretome of intestinal endothelial cells: putative impact on epithelial barrier dysfunction in IBD. Front. Cell Dev. Biol. 11, 1213383 (2023).","journal-title":"Front. Cell Dev. Biol."},{"key":"57124_CR63","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.3748\/wjg.v22.i3.1067","volume":"22","author":"D Cibor","year":"2016","unstructured":"Cibor, D. et al. Endothelial dysfunction in inflammatory bowel diseases: Pathogenesis, assessment and implications. World J. Gastroenterol. 22, 1067\u20131077 (2016).","journal-title":"World J. Gastroenterol."},{"key":"57124_CR64","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1093\/ibd\/izab251","volume":"28","author":"G Bamias","year":"2022","unstructured":"Bamias, G., Pizarro, T. T. & Cominelli, F. Immunological regulation of intestinal fibrosis in inflammatory bowel disease. Inflamm. Bowel Dis. 28, 337\u2013349 (2022).","journal-title":"Inflamm. Bowel Dis."},{"key":"57124_CR65","doi-asserted-by":"publisher","first-page":"295","DOI":"10.5217\/ir.2023.00029","volume":"21","author":"CH Lee","year":"2023","unstructured":"Lee, C. H., Koh, S. J., Radi, Z. A. & Habtezion, A. Animal models of inflammatory bowel disease: novel experiments for revealing pathogenesis of colitis, fibrosis, and colitis-associated colon cancer. Intest. Res. 21, 295\u2013305 (2023).","journal-title":"Intest. Res."},{"key":"57124_CR66","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/978-1-0716-1382-5_26","volume":"2299","author":"J Li","year":"2021","unstructured":"Li, J. et al. Mouse models of intestinal fibrosis. Methods Mol. Biol. 2299, 385\u2013403 (2021).","journal-title":"Methods Mol. Biol."},{"key":"57124_CR67","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.canlet.2021.08.005","volume":"520","author":"M Zhang","year":"2021","unstructured":"Zhang, M. et al. Anti-vascular endothelial growth factor therapy in breast cancer: Molecular pathway, potential targets, and current treatment strategies. Cancer Lett. 520, 422\u2013433 (2021).","journal-title":"Cancer Lett."},{"key":"57124_CR68","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1124\/pharmrev.120.000096","volume":"73","author":"S Xu","year":"2021","unstructured":"Xu, S. et al. Endothelial dysfunction in atherosclerotic cardiovascular diseases and beyond: From mechanism to pharmacotherapies. Pharm. Rev. 73, 924\u2013967 (2021).","journal-title":"Pharm. Rev."},{"key":"57124_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2020.100904","volume":"82","author":"MO Price","year":"2021","unstructured":"Price, M. O., Mehta, J. S., Jurkunas, U. V. & Price, F. W. Jr Corneal endothelial dysfunction: Evolving understanding and treatment options. Prog. Retin. Eye Res. 82, 100904 (2021).","journal-title":"Prog. Retin. Eye Res."},{"key":"57124_CR70","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15817-5","volume":"11","author":"V Barbier","year":"2020","unstructured":"Barbier, V. et al. Endothelial E-selectin inhibition improves acute myeloid leukaemia therapy by disrupting vascular niche-mediated chemoresistance. Nat. Commun. 11, 2042 (2020).","journal-title":"Nat. Commun."},{"key":"57124_CR71","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.immuni.2016.07.007","volume":"45","author":"MT Wong","year":"2016","unstructured":"Wong, M. T. et al. A high-dimensional atlas of human T cell diversity reveals tissue-specific trafficking and cytokine signatures. Immunity 45, 442\u2013456 (2016).","journal-title":"Immunity"},{"key":"57124_CR72","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/s13555-022-00876-x","volume":"13","author":"SK Tyring","year":"2023","unstructured":"Tyring, S. K. et al. Risankizumab in patients with moderate-to-severe atopic dermatitis: A phase 2, randomized, double-blind, placebo-controlled study. Dermatol Ther. 13, 595\u2013608 (2023).","journal-title":"Dermatol Ther."},{"key":"57124_CR73","doi-asserted-by":"publisher","first-page":"14211","DOI":"10.1074\/jbc.M114.548131","volume":"289","author":"RT Strachan","year":"2014","unstructured":"Strachan, R. T. et al. Divergent transducer-specific molecular efficacies generate biased agonism at a G protein-coupled receptor (GPCR). J. Biol. Chem. 289, 14211\u201314224 (2014).","journal-title":"J. Biol. Chem."},{"key":"57124_CR74","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-02401-7","volume":"9","author":"T Li","year":"2018","unstructured":"Li, T. et al. Homocysteine directly interacts and activates the angiotensin II type I receptor to aggravate vascular injury. Nat. Commun. 9, 11 (2018).","journal-title":"Nat. Commun."},{"key":"57124_CR75","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14335","volume":"8","author":"CH Liu","year":"2017","unstructured":"Liu, C. H. et al. Arrestin-biased AT1R agonism induces acute catecholamine secretion through TRPC3 coupling. Nat. Commun. 8, 14335 (2017).","journal-title":"Nat. Commun."},{"key":"57124_CR76","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/s41586-020-2569-1","volume":"587","author":"F Yang","year":"2020","unstructured":"Yang, F. et al. Structural basis of GPBAR activation and bile acid recognition. Nature 587, 499\u2013504 (2020).","journal-title":"Nature"},{"key":"57124_CR77","doi-asserted-by":"publisher","first-page":"12435","DOI":"10.1073\/pnas.1920310117","volume":"117","author":"J Kim","year":"2020","unstructured":"Kim, J. et al. The beta-arrestin-biased beta-adrenergic receptor blocker carvedilol enhances skeletal muscle contractility. Proc. Natl. Acad. Sci. USA 117, 12435\u201312443 (2020).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"57124_CR78","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2117054119","volume":"119","author":"L Ma","year":"2022","unstructured":"Ma, L. et al. Structural basis and molecular mechanism of biased GPBAR signaling in regulating NSCLC cell growth via YAP activity. Proc. Natl. Acad. Sci. USA 119, e2117054119 (2022).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"57124_CR79","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1126\/science.aaz0326","volume":"367","author":"CM Suomivuori","year":"2020","unstructured":"Suomivuori, C. M. et al. Molecular mechanism of biased signaling in a prototypical G protein-coupled receptor. Science 367, 881\u2013887 (2020).","journal-title":"Science"},{"key":"57124_CR80","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1126\/science.aay9813","volume":"367","author":"LM Wingler","year":"2020","unstructured":"Wingler, L. M. et al. Angiotensin and biased analogs induce structurally distinct active conformations within a GPCR. Science 367, 888\u2013892 (2020).","journal-title":"Science"},{"key":"57124_CR81","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/s41580-018-0049-3","volume":"19","author":"D Wootten","year":"2018","unstructured":"Wootten, D., Christopoulos, A., Marti-Solano, M., Babu, M. M. & Sexton, P. M. Mechanisms of signalling and biased agonism in G protein-coupled receptors. Nat. Rev. Mol. Cell Biol. 19, 638\u2013653 (2018).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"57124_CR82","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.immuni.2007.11.017","volume":"28","author":"TH Pham","year":"2008","unstructured":"Pham, T. H., Okada, T., Matloubian, M., Lo, C. G. & Cyster, J. G. S1P1 receptor signaling overrides retention mediated by G alpha i-coupled receptors to promote T cell egress. Immunity 28, 122\u2013133 (2008).","journal-title":"Immunity"},{"key":"57124_CR83","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/ni.1682","volume":"10","author":"IL Grigorova","year":"2009","unstructured":"Grigorova, I. L. et al. Cortical sinus probing, S1P1-dependent entry and flow-based capture of egressing T cells. Nat. Immunol. 10, 58\u201365 (2009).","journal-title":"Nat. Immunol."},{"key":"57124_CR84","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/s41584-022-00784-6","volume":"18","author":"N Burg","year":"2022","unstructured":"Burg, N., Salmon, J. E. & Hla, T. Sphingosine 1-phosphate receptor-targeted therapeutics in rheumatic diseases. Nat. Rev. Rheumatol. 18, 335\u2013351 (2022).","journal-title":"Nat. Rev. Rheumatol."},{"key":"57124_CR85","doi-asserted-by":"publisher","unstructured":"Xiong, Y. et al. CD4 T cell sphingosine 1-phosphate receptor (S1PR)1 and S1PR4 and endothelial S1PR2 regulate afferent lymphatic migration. Sci. Immunol. 4, https:\/\/doi.org\/10.1126\/sciimmunol.aav1263 (2019).","DOI":"10.1126\/sciimmunol.aav1263"},{"key":"57124_CR86","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1146\/annurev-immunol-020711-075011","volume":"30","author":"JG Cyster","year":"2012","unstructured":"Cyster, J. G. & Schwab, S. R. Sphingosine-1-phosphate and lymphocyte egress from lymphoid organs. Annu.Rev. Immunol. 30, 69\u201394 (2012).","journal-title":"Annu.Rev. Immunol."},{"key":"57124_CR87","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s00005-013-0264-8","volume":"62","author":"S Simmons","year":"2014","unstructured":"Simmons, S. & Ishii, M. Sphingosine-1-phosphate: a master regulator of lymphocyte egress and immunity. Arch. Immunol. Ther. Exp. 62, 103\u2013115 (2014).","journal-title":"Arch. Immunol. Ther. Exp."},{"key":"57124_CR88","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/nature02284","volume":"427","author":"M Matloubian","year":"2004","unstructured":"Matloubian, M. et al. Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1. Nature 427, 355\u2013360 (2004).","journal-title":"Nature"},{"key":"57124_CR89","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1161\/HYPERTENSIONAHA.117.09088","volume":"70","author":"A Cantalupo","year":"2017","unstructured":"Cantalupo, A. et al. S1PR1 (Sphingosine-1-Phosphate Receptor 1) signaling regulates blood flow and pressure. Hypertension 70, 426\u2013434 (2017).","journal-title":"Hypertension"},{"key":"57124_CR90","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1161\/CIRCRESAHA.120.318412","volume":"129","author":"MZ Akhter","year":"2021","unstructured":"Akhter, M. Z. et al. Programming to S1PR1(+) endothelial cells promotes restoration of vascular integrity. Circ. Res. 129, 221\u2013236 (2021).","journal-title":"Circ. Res."},{"key":"57124_CR91","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1016\/S0140-6736(21)00244-0","volume":"398","author":"MP McGinley","year":"2021","unstructured":"McGinley, M. P. & Cohen, J. A. Sphingosine 1-phosphate receptor modulators in multiple sclerosis and other conditions. Lancet 398, 1184\u20131194 (2021).","journal-title":"Lancet"},{"key":"57124_CR92","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.jhep.2023.03.018","volume":"79","author":"S Baweja","year":"2023","unstructured":"Baweja, S. et al. Hepatopulmonary syndrome is associated with low sphingosine-1-phosphate levels and can be ameliorated by the functional agonist fingolimod. J. Hepatol. 79, 167\u2013180 (2023).","journal-title":"J. Hepatol."},{"key":"57124_CR93","doi-asserted-by":"publisher","first-page":"578","DOI":"10.3748\/wjg.v17.i5.578","volume":"17","author":"WE Cromer","year":"2011","unstructured":"Cromer, W. E., Mathis, J. M., Granger, D. N., Chaitanya, G. V. & Alexander, J. S. Role of the endothelium in inflammatory bowel diseases. World J. Gastroenterol. 17, 578\u2013593 (2011).","journal-title":"World J. Gastroenterol."},{"key":"57124_CR94","doi-asserted-by":"publisher","unstructured":"Dubsky, M. et al. Endothelial dysfunction in diabetes mellitus: New insights. Int. J. Mol. Sci. 24, https:\/\/doi.org\/10.3390\/ijms241310705 (2023).","DOI":"10.3390\/ijms241310705"},{"key":"57124_CR95","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.864185","volume":"9","author":"P Anyfanti","year":"2022","unstructured":"Anyfanti, P. et al. Endothelial dysfunction in psoriasis: An updated review. Front. Med. 9, 864185 (2022).","journal-title":"Front. Med."},{"key":"57124_CR96","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/s41581-021-00489-1","volume":"18","author":"G Molema","year":"2022","unstructured":"Molema, G., Zijlstra, J. G., van Meurs, M. & Kamps, J. Renal microvascular endothelial cell responses in sepsis-induced acute kidney injury. Nat. Rev. Nephrol. 18, 95\u2013112 (2022).","journal-title":"Nat. Rev. Nephrol."},{"key":"57124_CR97","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1038\/s41590-022-01362-4","volume":"23","author":"S Houston","year":"2022","unstructured":"Houston, S. Immunosuppression. Nat. Immunol. 23, 1520 (2022).","journal-title":"Nat. Immunol."},{"key":"57124_CR98","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1136\/gutjnl-2013-305300","volume":"62","author":"O Bernheim","year":"2013","unstructured":"Bernheim, O. et al. The management of immunosuppression in patients with inflammatory bowel disease and cancer. Gut 62, 1523\u20131528 (2013).","journal-title":"Gut"},{"key":"57124_CR99","doi-asserted-by":"publisher","first-page":"e1302","DOI":"10.1093\/cid\/ciaa1189","volume":"73","author":"MB Roberts","year":"2021","unstructured":"Roberts, M. B. & Fishman, J. A. Immunosuppressive agents and infectious risk in transplantation: Managing the \u201cNet State of Immunosuppression. Clin. Infect. Dis. 73, e1302\u2013e1317 (2021).","journal-title":"Clin. Infect. Dis."},{"key":"57124_CR100","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1038\/mt.2014.41","volume":"22","author":"D Blat","year":"2014","unstructured":"Blat, D., Zigmond, E., Alteber, Z., Waks, T. & Eshhar, Z. Suppression of murine colitis and its associated cancer by carcinoembryonic antigen-specific regulatory T cells. Mol. Ther. 22, 1018\u20131028 (2014).","journal-title":"Mol. Ther."},{"key":"57124_CR101","doi-asserted-by":"publisher","first-page":"2900","DOI":"10.1038\/nprot.2006.446","volume":"1","author":"C Becker","year":"2006","unstructured":"Becker, C., Fantini, M. C. & Neurath, M. F. High resolution colonoscopy in live mice. Nat. Protoc. 1, 2900\u20132904 (2006).","journal-title":"Nat. Protoc."},{"key":"57124_CR102","doi-asserted-by":"publisher","unstructured":"Helms, M. N., Torres-Gonzalez, E., Goodson, P. & Rojas, M. Direct tracheal instillation of solutes into mouse lung. J. Vis. Exp. https:\/\/doi.org\/10.3791\/1941 (2010).","DOI":"10.3791\/1941"},{"key":"57124_CR103","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/j.chom.2023.04.018","volume":"31","author":"W Liang","year":"2023","unstructured":"Liang, W. et al. Airway dysbiosis accelerates lung function decline in chronic obstructive pulmonary disease. Cell Host Microbe 31, 1054\u20131070 e1059 (2023).","journal-title":"Cell Host Microbe"},{"key":"57124_CR104","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.cell.2011.04.022","volume":"145","author":"E Elinav","year":"2011","unstructured":"Elinav, E. et al. NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis. Cell 145, 745\u2013757 (2011).","journal-title":"Cell"},{"key":"57124_CR105","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1038\/ncb3632","volume":"19","author":"R Cruz-Acuna","year":"2017","unstructured":"Cruz-Acuna, R. et al. Synthetic hydrogels for human intestinal organoid generation and colonic wound repair. Nat. Cell Biol. 19, 1326\u20131335 (2017).","journal-title":"Nat. Cell Biol."},{"key":"57124_CR106","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1038\/s41422-021-00566-x","volume":"31","author":"Y Yuan","year":"2021","unstructured":"Yuan, Y. et al. Structures of signaling complexes of lipid receptors S1PR1 and S1PR5 reveal mechanisms of activation and drug recognition. Cell Res. 31, 1263\u20131274 (2021).","journal-title":"Cell Res."},{"key":"57124_CR107","doi-asserted-by":"publisher","first-page":"3171","DOI":"10.1016\/j.molcel.2023.07.030","volume":"83","author":"C Zhao","year":"2023","unstructured":"Zhao, C. et al. Biased allosteric activation of ketone body receptor HCAR2 suppresses inflammation. Mol. Cell 83, 3171\u20133187 (2023).","journal-title":"Mol. Cell"},{"key":"57124_CR108","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36673-z","volume":"14","author":"J Zhao","year":"2023","unstructured":"Zhao, J. et al. Prospect of acromegaly therapy: molecular mechanism of clinical drugs octreotide and paltusotine. Nat. Commun. 14, 962 (2023).","journal-title":"Nat. Commun."},{"key":"57124_CR109","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/nmeth.4193","volume":"14","author":"SQ Zheng","year":"2017","unstructured":"Zheng, S. Q. et al. MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy. Nat. Methods 14, 331\u2013332 (2017).","journal-title":"Nat. Methods"},{"key":"57124_CR110","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jsb.2015.11.003","volume":"193","author":"K Zhang","year":"2016","unstructured":"Zhang, K. Gctf: Real-time CTF determination and correction. J. Struct. Biol. 193, 1\u201312 (2016).","journal-title":"J. Struct. Biol."},{"key":"57124_CR111","doi-asserted-by":"publisher","first-page":"4169","DOI":"10.1042\/BCJ20210708","volume":"478","author":"D Kimanius","year":"2021","unstructured":"Kimanius, D., Dong, L., Sharov, G., Nakane, T. & Scheres, S. H. W. New tools for automated cryo-EM single-particle analysis in RELION-4.0. Biochem. J. 478, 4169\u20134185 (2021).","journal-title":"Biochem. J."},{"key":"57124_CR112","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nmeth.4169","volume":"14","author":"A Punjani","year":"2017","unstructured":"Punjani, A., Rubinstein, J. L., Fleet, D. J. & Brubaker, M. A. cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat. Methods 14, 290\u2013296 (2017).","journal-title":"Nat. Methods"},{"key":"57124_CR113","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1002\/pro.3943","volume":"30","author":"EF Pettersen","year":"2021","unstructured":"Pettersen, E. F. et al. UCSF ChimeraX: Structure visualization for researchers, educators, and developers. Protein Sci. 30, 70\u201382 (2021).","journal-title":"Protein Sci."},{"key":"57124_CR114","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1107\/S0907444910007493","volume":"66","author":"P Emsley","year":"2010","unstructured":"Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr. D. Biol. Crystallogr. 66, 486\u2013501 (2010).","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"57124_CR115","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1107\/S2059798319011471","volume":"75","author":"D Liebschner","year":"2019","unstructured":"Liebschner, D. et al. Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix. Acta Crystallogr. D. Struct. Biol. 75, 861\u2013877 (2019).","journal-title":"Acta Crystallogr. D. Struct. Biol."},{"key":"57124_CR116","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1002\/jcc.20945","volume":"29","author":"S Jo","year":"2008","unstructured":"Jo, S., Kim, T., Iyer, V. G. & Im, W. CHARMM-GUI: a web-based graphical user interface for CHARMM. J. Comput. Chem. 29, 1859\u20131865 (2008).","journal-title":"J. Comput. Chem."},{"key":"57124_CR117","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1021\/acs.jctc.5b00935","volume":"12","author":"J Lee","year":"2016","unstructured":"Lee, J. et al. CHARMM-GUI Input generator for NAMD, GROMACS, AMBER, OpenMM, and CHARMM\/OpenMM simulations using the CHARMM36 additive force field. J. Chem. Theory Comput. 12, 405\u2013413 (2016).","journal-title":"J. Chem. Theory Comput."},{"key":"57124_CR118","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/nmeth.4067","volume":"14","author":"J Huang","year":"2017","unstructured":"Huang, J. et al. CHARMM36m: an improved force field for folded and intrinsically disordered proteins. Nat. Methods 14, 71\u201373 (2017).","journal-title":"Nat. Methods"},{"key":"57124_CR119","doi-asserted-by":"publisher","DOI":"10.1063\/5.0018516","volume":"153","author":"S Pall","year":"2020","unstructured":"Pall, S. et al. Heterogeneous parallelization and acceleration of molecular dynamics simulations in GROMACS. J. Chem. Phys. 153, 134110 (2020).","journal-title":"J. Chem. Phys."},{"key":"57124_CR120","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1038\/s41586-023-06804-z","volume":"624","author":"Z Xu","year":"2023","unstructured":"Xu, Z. et al. Ligand recognition and G-protein coupling of trace amine receptor TAAR1. Nature 624, 672\u2013681 (2023).","journal-title":"Nature"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-57124-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-57124-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-57124-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T17:16:02Z","timestamp":1740071762000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-57124-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,20]]},"references-count":120,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["57124"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-57124-x","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,20]]},"assertion":[{"value":"2 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1826"}}